BELLICUM PHARMACEUTICALS, INC Annual Operating Income (Loss) in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2022.
  • Bellicum Pharmaceuticals, Inc Operating Income (Loss) for the quarter ending September 30, 2023 was -$773K, a 89.2% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc Operating Income (Loss) for the twelve months ending September 30, 2023 was -$23.8M, a 3.7% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2022 was -$27M, a 8.51% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2021 was -$24.9M, a 51.9% increase from 2020.
  • Bellicum Pharmaceuticals, Inc annual Operating Income (Loss) for 2020 was -$51.7M, a 40.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.